P2RX7 and Alzheimer disease: Furthermore, McLarnon et al. demonstrated that Ca2+ responses in adult microglial cells from Alzheimer’s disease patients were significantly increased following Aβ1–42 pre-treatment when activated by a P2X7 selective agonist BzATP (McLarnon et al., 2006).